Role of Frailty in Bleeding Risk Prediction in Acute Coronary Syndrome
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorAssiut University
About this trial
Studying the incremental role of frailty in predicting in-hospital, short-term (30 days), and mid-term (6 months) bleeding in ACS patients.
Eligibility criteria
Qualifiers
- Patients must be suffering from acute coronary syndrome ( STEMI - NSTEMI ) at the time of recruitment
- Patients must be older than 65 years
Disqualifiers
- Patients younger than 65 years
- Refusal of participation
- In - hospital death unrelated to bleeding
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov